Irvine, United States
Red Chip Enterprises is a leading management services provider for Hemophilia Treatment Centers (HTCs) offering 340B outpatient factor programs. The company collaborates with 18 HTCs across 11 states and has expanded its operations to possess pharmacy licenses in all 50 states. Notably, Red Chip is involved in limited-distribution models, particularly for manufacturers supplying high-cost drugs to small, chronically-ill patient populations. The organization is recognized for its exceptional billing and collection services for these high-cost prescription medications.
Founded in 2001, Red Chip operates within the Health Care sector, catering specifically to the needs of HTCs and their patient programs. With a strong presence in multiple states, Red Chip has positioned itself as a vital partner in delivering crucial services within the healthcare industry.
As of now, there is no publicly disclosed information regarding last investment or last investment investors for Red Chip Enterprises.
